Kymera Therapeutics
Alice McDonald has over 20 years of experience in drug discovery and translational medicine. Alice has held various roles at Kymera Therapeutics, including Senior Director of Translational Medicine and Director. Prior to that, they worked at Epizyme as a Senior Scientific Manager, specializing in translational biomarkers. Alice also has experience as a Scientist at Millennium Pharmaceuticals.
Alice McDonald attended Colby College from 1991 to 1995. No degree or field of study information is provided.
Kymera Therapeutics
5 followers
Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.